Application 219159

Type: ANDA
Sponsor: GRAVITI PHARMS

Application Products#

Product, Drug, Ingredient table
Product	Drug	Ingredient	Form	Strength	Reference drug	Reference standard
001	GLIPIZIDE	GLIPIZIDE	TABLET;ORAL	5MG	No	No
002	GLIPIZIDE	GLIPIZIDE	TABLET;ORAL	10MG	No	No

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A219159-001	GLIPIZIDE	GLIPIZIDE	5MG	TABLET / ORAL	AB		2026-03-04
A219159-002	GLIPIZIDE	GLIPIZIDE	10MG	TABLET / ORAL	AB		2026-03-04

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-product	TE code
A219159-001	AB
A219159-002	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	A219159-001	GLIPIZIDE	5MG	TABLET / ORAL	AB	2026-03-04	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A219159-002	GLIPIZIDE	10MG	TABLET / ORAL	AB	2026-03-04	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A219159-001	GLIPIZIDE	5MG	TABLET / ORAL	AB	2026-03-04	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A219159-002	GLIPIZIDE	10MG	TABLET / ORAL	AB	2026-03-04	`caaa826d4ba7…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	A219159-001	GLIPIZIDE	5MG	TABLET / ORAL	AB	2026-03-04	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	A219159-002	GLIPIZIDE	10MG	TABLET / ORAL	AB	2026-03-04	`a50c72e98297…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-09-14 22:38:34	2026-08	A219159-001	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A219159-002	AB	1	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A219159-001	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A219159-002	AB	1	`caaa826d4ba7…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	A219159-001	AB	1	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	A219159-002	AB	1	`a50c72e98297…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 6 of 6 · 102 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Glipizide	GLIPIZIDE	Aphena Pharma Solutions - Tennessee, LLC	9f7f880a-1060-431a-a155-884e8cfbdf22	2018-08-15	Warnings, Adverse reactions	Name fallback brand name: Glipizide generic name: GLIPIZIDE
Glipizide	GLIPIZIDE	Aphena Pharma Solutions - Tennessee, LLC	d6c016f7-bf93-4322-a179-d4798234b381	2017-08-18	Warnings, Adverse reactions	Name fallback brand name: Glipizide generic name: GLIPIZIDE

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.